VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

BTOG 2021 | Novel therapies on the horizon for lung cancer

Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, UK, discusses novel therapies for lung cancer such as those targeting KRAS mutations and antibody-drug conjugates for the treatment of HER2-driven non-small cell lung cancer. This interview took place during the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter